Is donor obesity related to liver steatosis and liver graft dysfunction in liver transplantation?

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Transplantation Proceedings

• Publication date

  2000-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0041-1345(00)01588-8PMID 11120087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary graft dysfunction after liver transplantation: from pathogenesis to prevention.

  1997cited by this paper
• Entwicklung einer kompletten Lebercirrhose bei Hyperphagie-bedingter Fettleber

  1994cited by this paper
• [Development of complete liver cirrhosis in hyperphagia-induced fatty liver].

  1994cited by this paper
• Definition and Classification of Negative Outcomes in Solid Organ Transplantation Application in Liver Transplantation

  1994cited by this paper
• Liver transplantation in patients with severe obesity.

  1994cited by this paper
• Liver pathology in morbidly obese patients with and without diabetes.

  1990cited by this paper
• Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors

  1990cited by this paper
• Diagnosis and prevalence of obesity.

  1989cited by this paper
• Hepatic morphology in obesity

  1981cited by this paper
• Fatty liver hepatitis and cirrhosis in obese patients.

  1979cited by this paper

• Impact of Donor Obesity on Graft and Recipient Survival Outcomes After Liver Transplantation: A Systematic Review and Meta-analysis

  2024cites this paper
• Influencing Factor Analysis on Initial Poor Graft Function after Liver Transplantation

  2016cites this paper
• Liver Transplantation and Donor Body Mass Index >30: Use or Refuse?

  2016cites this paper
• Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm

  2013cites this paper
• Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure.

  2004cites this paper
• Hepatic steatosis and liver transplantation

  2004cites this paper
• In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.

  2003cites this paper
• The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation

  2003cites this paper